Back to search

Article

CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction

2023-02-13

Abstract excerpt

<title>Abstract</title> <p>Previous study from our lab has revealed a new role of CD47 in regulating adipose tissue function, energy homeostasis and the development of obesity and metabolic disease in CD47 deficient mice. In this study, the therapeutic potential of an antisense oligonucleotide (ASO) targeting to CD47 in obesity and its-associated complications was determined in two obese mouse models (diet induce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2034ee3b-0d5b-5398-9c4c-a772a6aefa75
DOI
10.21203/rs.3.rs-2362549/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunctionDOI 10.21203/rs.3.rs-2362549/v2
Select a neighboring publication to make it the new centre.